MicroRNA-185-5p: a marker of brain-sparing in foetuses with late-onset growth restriction

References

• American College of Obstetricians and Gynecologists. Practice bulletin no. 134: fetal growth restriction. Obstet Gynecol. 2013;121:1122–1133.
   Google Scholar
• Lees C, Marlow N, Arabin B, TRUFFLE Group, et al. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol. 2013;42:400–408.
   Google Scholar
• Yzydorczyk C, Armengaud JB, Peyter AC, et al. Endothelial dysfunction in individuals born after fetal growth restriction: cardiovascular and renal consequences and preventive approaches. J Dev Orig Health Dis. 2017;8:448–464.
   Google Scholar
• Figueras F, Gratacós E. Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther. 2014;36:86–98.
   Google Scholar
• Miller SL, Huppi PS, Mallard C. The consequences of fetal growth restriction on brain structure and neurodevelopmental outcome. J Physiol. 2016;594:807–823.
   Google Scholar
• Quezada S, Castillo-Melendez M, Walker DW, et al. Development of the cerebral cortex and the effect of the intrauterine environment. J Physiol. 2018;59:5665–5674.
   Google Scholar
• Triunfo S, Crispi F, Gratacos E, et al. Prediction of delivery of small for gestational age neonates and adverse perinatal outcomes by feto-placental Doppler at 37 weeks’ gestation. Ultrasound Obstet Gynecol. 2018;52:430–441.
   Google Scholar
• Morales-Roselló J, Khalil A, Fornés-Ferrer V, et al. Accuracy of the fetal cerebroplacental ratio for the detection of intrapartum compromise in nonsmall fetuses. J Matern Fetal Neonatal Med. 2019;32:2842–2852.
   Google Scholar
• Bligh LN, Alsolai AA, Greer RM, et al. Cerebroplacental ratio thresholds measured within 2 weeks before birth and risk of Cesarean section for intrapartum fetal compromise and adverse neonatal outcome. Ultrasound Obstet Gynecol. 2018;52:340–346.
   Google Scholar
• Bligh LN, Alsolai AA, Greer RM, et al. Pre-labour screening for intrapartum fetal compromise in low risk pregnancies at term: cerebroplacental ratio and placental growth factor. Ultrasound Obstet Gynecol. 2018;52:750–756.
   Google Scholar
• Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136:642e55.
   Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215e33.
   Google Scholar
• Ichihara A, Jinnin M, Yamane K, et al. microRNA-mediated keratinocyte hyperproliferation in psoriasis vulgaris. Br J Dermatol. 2011;165:1003e10.
   Google Scholar
• Vlachos IS, Paraskevopoulou MD, Karagkouni D, et al. DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions. Nucleic Acids Res. 2015;43( Database issue):D153–9.
   Google Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15–20.
   Google Scholar
• Bandara KV, Michael MZ, Gleadle JM. MicroRNA biogenesis in hypoxia. Microrna. 2017;6:80–96.
   Google Scholar
• Nallamshetty S, Chan SY, Loscalzo J. Hypoxia: a master regulator of microRNA biogenesis and activity. Free Radic Biol Med. 2013;64:20–30.
   Google Scholar
• Rupaimoole R, Wu SY, Pradeep S, et al. Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression. Nat Commun. 2014 Oct;5:5202.
   Google Scholar
• Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell. 2019;176:1248–1264.
   Google Scholar
• Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25:581–611.
   Google Scholar
• Theis V, Theiss C. VEGF - a stimulus for neuronal development and regeneration in the CNS and PNS. Curr Protein Pept Sci. 2018;19:589–597.
   Google Scholar
• Ruiz de Almodovar C, Lambrechts D, Mazzone M, et al. Role and therapeutic potential of VEGF in the nervous system. Physiol Rev. 2009;89:607–648.
   Google Scholar
• Morales-Roselló J, Khalil A, Morlando M, et al. Doppler reference values of the fetal vertebral and middle cerebral arteries, at 19-41 weeks gestation. J Matern Fetal Neonatal Med. 2015;28:338–343.
   Google Scholar
• Acharya G, Wilsgaard T, Berntsen GK, et al. Reference ranges for serial measurements of umbilical artery Doppler indices in the second half of pregnancy. Am J Obstet Gynecol. 2005;192:937–944.
   Google Scholar
• Baschat AA, Gembruch U. The cerebroplacental Doppler ratio revisited. Ultrasound Obstet Gynecol. 2003;21:124–127.
   Google Scholar
• Figueras F, Meler E, Iraola A, et al. Customized birthweight standards for a Spanish population. Eur J Obstet Gynecol Reprod Biol. 2008;136:20–24.
   Google Scholar
• Morales-Roselló J, Khalil A, Morlando M, et al. Changes in fetal Doppler indices as a marker of failure to reach growth potential at term. Ultrasound Obstet Gynecol. 2014;43:303–310.
   Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25:402–408.
   Google Scholar
• Morales-Roselló J, Khalil A. Fetal cerebral redistribution: a marker of compromise regardless of fetal size. Ultrasound Obstet Gynecol. 2015;46:385–388.
   Google Scholar
• Morales-Roselló J, Khalil A, Morlando M, et al. Poor neonatal acid-base status in term fetuses with low cerebroplacental ratio. Ultrasound Obstet Gynecol. 2015;45:156–161.
   Google Scholar
• Khalil AA, Morales-Rosello J, Elsaddig M, et al. The association between fetal Doppler and admission to neonatal unit at term. Am J Obstet Gynecol. 2015;213:57.e1–7.
   Google Scholar
• Khalil AA, Morales-Rosello J, Morlando M, et al. Is fetal cerebroplacental ratio an independent predictor of intrapartum fetal compromise and neonatal unit admission? Am J Obstet Gynecol. 2015;213:54.e1–10.
   Google Scholar
• Cai M, Kolluru GK, Ahmed A. Small molecule, big prospects: microRNA in pregnancy and its complications. J Pregnancy. 2017;2017:6972732.
   Google Scholar
• Koh MY, Powis G. Passing the baton: the HIF switch. Trends Biochem Sci. 2012 Sept;37(9):364–372.
   Google Scholar
• Yang SL, Wu C, Xiong ZF, et al. Progress on hypoxia-inducible factor-3: its structure, gene regulation and biological function (Review). Mol Med Rep. 2015;12:2411–2416.
   Google Scholar
• Ramakrishnan S, Anand V, Roy S. Vascular endothelial growth factor signaling in hypoxia and inflammation. J Neuroimmune Pharmacol. 2014;9:142–160.
   Google Scholar
• Storkebaum E, Lambrechts D, Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays. 2004;26:943–954.
   Google Scholar
• Shiote M, Nagano I, Ilieva H, et al. Reduction of a vascular endothelial growth factor receptor, fetal liver kinase-1, by antisense oligonucleotides induces motor neuron death in rat spinal cord exposed to hypoxia. Neuroscience. 2005;132:175–182.
   Google Scholar
• Serocki M, Bartoszewska S, Janaszak-Jasiecka A, et al. miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target. Angiogenesis. 2018;21:183–202.
   Google Scholar
• Lisy K, Peet DJ. Turn me on: regulating HIF transcriptional activity. Cell Death Differ. 2008;15:642–649.
   Google Scholar
• Ho JJ, Metcalf JL, Yan MS, et al. Functional importance of Dicer protein in the adaptive cellular response to hypoxia. J Biol Chem. 2012;287:29003–29020.
   Google Scholar
• Lu ZJ, Lu LG, Tao KZ, et al. MicroRNA-185 suppresses growth and invasion of colon cancer cells through inhibition of the hypoxia-inducible factor-2α pathway in vitro and in vivo. Mol Med Rep. 2014;10:2401–2408.
   Google Scholar
• Agrawal R, Pandey P, Jha P, et al. Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing. BMC Genomics. 2014;15:686.
   Google Scholar
• Fan L, Tan B, Li Y, et al. Upregulation of miR-185 promotes apoptosis of the human gastric cancer cell line MGC803. Mol Med Rep. 2018;17:3115–3122.
   Google Scholar
• Akçakaya P, Ekelund S, Kolosenko I, et al. miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer.Int. J Oncol. 2011;39:311–318.
   Google Scholar
• Yuan HX, Zhang JP, Kong WT, et al. Elevated microRNA-185 is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in clear cell renal cell carcinoma. Tumour Biol. 2014;35:12757–12763.
   Google Scholar
• Eilertsen M, Pettersen I, Andersen S, et al. In NSCLC, VEGF-A response to hypoxia may differ between squamous cell and adenocarcinoma histology. Anticancer Res. 2012;32:4729–4736.
   Google Scholar
• Liu X, Wang D, Yang X. Huayu Tongmai Granules protects against vascular endothelial dysfunction via up-regulating miR-185 and down-regulating RAGE. Biosci Rep. 2018;38:BSR20180674.
   Google Scholar
• Wen Z, Zhang J, Tang P, et al. Overexpression of miR‐185 inhibits autophagy and apoptosis of dopaminergic neurons by regulating the AMPK/mTOR signaling pathway in Parkinson’s disease. Mol Med Rep. 2018;17:131–137.
   Google Scholar
• Tsao PN. Wei SC Prenatal hypoxia downregulates the expression of pulmonary vascular endothelial growth factor and its receptors in fetal mice. Neonatology. 2013;103:300–307.
   Google Scholar
• Malamitsi-Puchner A, Boutsikou T, Economou E, et al. Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates. Mediators Inflamm. 2005;2005:293–297.
   Google Scholar
• Whitehead CL, Teh WT, Walker SP, et al. Circulating MicroRNAs in maternal blood as potential biomarkers for fetal hypoxia in-utero. PLoS One. 2013;8:e78487.
   Google Scholar
• Chiofalo B, Laganà AS, Vaiarelli A, et al. Do miRNAs play a role in fetal growth restriction? A fresh look to a busy corner. Biomed Res Int. 2017;2017:6073167.
   Google Scholar
• Awamleh Z, Gloor GB, Han VKM. Placental microRNAs in pregnancies with early onset intrauterine growth restriction and preeclampsia: potential impact on gene expression and pathophysiology. BMC Med Genomics. 2019;12:91.
   Google Scholar
• Thamotharan S, Chu A, Kempf K, et al. Differential microRNA expression in human placentas of term intra-uterine growth restriction that regulates target genes mediating angiogenesis and amino acid transport. PLoS One. 2017;12:e0176493.
   Google Scholar
• Higashijima A, Miura K, Mishima H, et al. Characterization of placenta-specific microRNAs in fetal growth restriction pregnancy. Prenat Diagn. 2013;33:214–222.
   Google Scholar
• Kim SH, MacIntyre DA, Binkhamis R, et al. Maternal plasma miRNAs as potential biomarkers for detecting risk of small-for-gestational-age births. EBioMedicine. 2020;62:103145.
   Google Scholar
• Li Y, Liu J. MicroRNA-206 predicts raised fetal growth retardation risk through the interaction with vascular endothelial growth factor in pregnancies. Medicine (Baltimore). 2020;99:e18897.
   Google Scholar
• Tang L, He G, Liu X, et al. Progress in the understanding of the etiology and predictability of fetal growth restriction. Reproduction. 2017;153:R227–R240.
   Google Scholar